Teva’s Generic Pravachol Will Be Approved – With Exclusivity, FDA Decrees
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has determined that a court dismissal does not constitute a decision under the “court decision trigger” provision, although the agency’s stance must be affirmed by the D.C. district court.